J3110 Teriparatide injection
Also known as: teriparatide, Forteo, parathyroid hormone analog
Teriparatide (Forteo) injection is a recombinant human parathyroid hormone analog used for osteoporosis treatment in men and postmenopausal women at high fracture risk.
In Plain Language
bone-building injection; osteoporosis treatment
Clinical Context
Indicated for osteoporosis with high fracture risk. Stimulates new bone formation through parathyroid hormone receptor signaling. Administered subcutaneously daily for up to 2 years. Often used after bisphosphonate therapy.
RVU Information
CPT J3110 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3110?
CPT J3110 (Teriparatide injection) is a J Codes (Drugs) code. Teriparatide (Forteo) injection is a recombinant human parathyroid hormone analog used for osteoporosis treatment in men and postmenopausal women at high fracture risk.
How is J3110 administered?
CPT J3110 is administered by a healthcare provider, typically via injection or infusion. Indicated for osteoporosis with high fracture risk. Stimulates new bone formation through parathyroid hormone receptor signaling. Administered subcutaneously daily for up to 2 years. Often used after bisphosphonate therapy. It is used by Endocrinology, Rheumatology, Orthopedic Surgery.
When is CPT J3110 used?
Indicated for osteoporosis with high fracture risk. Stimulates new bone formation through parathyroid hormone receptor signaling. Administered subcutaneously daily for up to 2 years. Often used after bisphosphonate therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.